Fundraising FoxMontreux Equity Partners — Full Portfolio
20 tracked investments · listed companies and verified rows first
Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms.
BiotechHealthtechMedical DevicesAliso Viejo, US
Thomas W. Burns(Chief Executive Officer and Chairman of the Board)
Co-investorsAvedro, Inc.
Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery.
BiotechHealthtechMedical DevicesSan Jose, US
LAUREN CRISTINA(Executive Officer)inSri Radhakrishnan(Chief Technology Officer)inMICHAEL BAKER(Executive Officer, Director)inGlendon E. French(Chief Executive Officer and Director)Derrick Sung(Chief Operating Officer and Chief Financial Officer)inGeoffrey Beran Rose(Chief Commercial Officer)
Co-investorsBand of AngelsHealthCapKaiser Permanente VenturesKleiner PerkinsLatterell Venture PartnersAlly Bridge Group
SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians.
HealthtechMedical DevicesSan Jose, US
Mark Reiley(Director)inJeffrey W. Dunn(Executive Officer, Director)Robert E. Johnson(Executive Officer)Dan Murray(Executive Officer)Laura A. Francis(Chief Executive Officer)
BoardTimothy E. Davis(Director)
Co-investorsArboretum VenturesOrbiMed
Dignify Therapeutics is developing drug programs that induce on-demand defecation and urination to treat functional bowel and bladder disorders, including incontinence and retention associated with neurological conditions and aging.
BiotechDigital HealthMedical DevicesResearch Triangle Park, US
Edward C Burgard(Executive Officer, Director, Promoter)Karl Thor(Chief Scientific Officer)inBenny Ward(Executive Officer, Director, Promoter)inAnthony DiTonno(CEO)Ed Burgard(President)Jeff Welch(Chief Operating Officer)
Board seatHoward D. Palefsky· per SEC Form D · $3M raise · filed Sep 2026
Co-investorsEshelman Ventures, LLCRA Capital
Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types.
ConsumerDirect to ConsumerHealthtechWellness & FitnessCarlsbad, US
Stephen Loomis(Executive Officer)Mary Fisher(Executive Officer, Director)inTheodore Ebel(Executive Officer)Josie Juncal-Schwarz(Executive Officer)
BoardM Bolyard(Director)Brian Dovey(Director)in
Co-investors1315 CapitalAisling CapitalRevelation PartnersDomain AssociatesHealthCare Ventures, LLCLongwood Fund+2 more
Tebra provides an integrated electronic health record and medical billing platform for independent healthcare practices, including EHR tools, claims management, patient payments, and scheduling capabilities.
Digital HealthEnterprise SoftwareHealthtechSaaSIrvine, US
DANIEL RODRIGUES(Executive Officer, Director)JIM LIM(Director)PERRY WALLACK(Director)MICHAEL MATLY(Director)ROB REID(Director)DAVID COZZENS(Director)
Co-investorsEscalate Capital PartnersGolub GrowthSaints CapitalWestern Technology InvestmentGreenspring AssociatesHLM Investment Partners+4 more
Developed a robotic surgical arm for knee and hip arthroplasty; acquired by Stryker for $1.65B in 2013.
Co-investorsAPERTURE Venture PartnersLumira Ventures
Mindbody provides software and a consumer app platform for fitness, beauty, and wellness businesses to manage operations, attract clients, and book classes and appointments.
AI & Machine LearningB2B MarketplacesCloud ComputingSaaSWellness & FitnessCalifornia, US
Richard L. Stollmeyer(Executive Officer, Director, Promoter)Blake Beltram(Founder)inBrad Wills(Executive Officer)inBrett White(Executive Officer)inChet Brandenburg(Executive Officer)inKimberly Lytikainen(Executive Officer)in
Co-investorsBessemer Venture PartnersEastward Capital PartnersFJ LabsGolub GrowthIVP (Institutional Venture Partners)Lead Edge Capital+7 more
Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases.
BiotechHealthtechLa Jolla, US
Preston Klassen(Executive Officer)inJoseph Hagan(Executive Officer)Michael Narachi(Executive Officer, Director)Thomas Cannell(Executive Officer)
BoardEckard Weber(Director)Brian H. Dovey(Director)in
Co-investorsCross Creek AdvisorsNew Enterprise Associates (NEA)Sofinnova VenturesDomain AssociatesDomain Partners
TigerConnect provides a clinical communication and collaboration platform for hospitals and healthcare organizations, offering HIPAA-compliant messaging, scheduling, patient transfer, and AI-driven workflow tools.
AI & Machine LearningDigital HealthHealthtechSaaS
Brad Brooks(Founder)inAndrew Brooks(Founder)inSean O'Neal(CEO)inTim Goodwin(Chief Technology Officer)inSheeza Hussain(Chief Growth Officer)inBrian Kaminski(Chief Customer Officer)in
Co-investorsVista Equity PartnersCorewell Health VenturesNew Science VenturesNorwest Venture PartnersOrbiMedHealthQuest Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Adigica HealthAsthmatxCerexaPeninsula PharmaceuticalsPsilosQuestcorSoluna HealthSonoma PharmaceuticalsTebraTobira Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.